2022 Speakers

Nida Sen

Retina Global Clinical Development

Janssen

Lauren Ayton

Associate Professor, & Head - Vision Optimisation

University of Melbourne

Lee Morris

Patient

Luxturna Patient (UK)

Maen Obeidat

Executive Director - Therapeutics Area Head, Biomarker Development, Ophthalmology

Novartis

Markus Peters

Chief Executive Officer

Aevitas Therapeutics (formerly)

Matthew Wood

Luxturna Patient (UK)

Rachel Eclov

Gene Therapy Development Project Leader

Kriya Therapeutics

Samarendra Mohanty

Chief Scientific Officer & President

Nanoscope Therapeutics

Sanghoon Kim

Project Engineer

Nanoscope Therapeutics

Subrata Batabyal

Senior Technical Officer

Nanoscope Technologies

Viral Kansara

Vice President of Preclinical Development

Clearside Biomedical

Yoreh Barak

Director of Retina, Department of Ophthalmology

Everads Therapy

Diane Doughty

Director of Device Development

REGENXBIO

Catherine Cukras

Director of the Medical Retina Fellowship Program

National Eye Institute (NEI)

Ramkumar Ramamirtham

Associate Director & Optometrist

Novartis (NIBR)

Shane Hegarty

Chief Scientific Officer & Co Founder

AXONIS Therapeutics

Amy Mawdesley

Product Manager

Newcells Biotech

Brianna Barrett

Associate Director Technical Sales

Forge Biologics

Simon Kaja

Chief Scientific Officer & Vice President

Experimentica

Cathleen Gonzales

Director of Pharmacology

Intergalactic Therapeutics

Eric Buckland

Founder & Chief Executive Officer

Translational Imaging Innovations (TII)

Miquel Vila-Perello

Chief Executive Officer & Chief Scientific Officer

SpliceBio

Abraham Scaria

Chief Scientific Offier

AGTC

Aniz Girach

Chief Medical Officer

ProQR

Arun Upadhyay

Senior Vice Preisent of Research & Development

Ocugen

Ashwath Jayagopal

Chief Scientific Officer

Opus Genetics

Catherine O’Riordan

Head Translational Cluster, Genomics Unit

Sanofi

Catarina Santos

Europe Medical Director of Ophthalmology

Novartis

Rosario Fernandez-Godi

Director, Head of Retina Biology Lab

Intergalactic Therapeutics

Claire Gelfman

Chief Scientific Officer

Foundation Fighting Blindness

Daniel Chung

Chief Medical Officer

SparingVision

Erin O’Neil

Attending Physician

Children’s Hospital of Philadelphia

Francis Tukov

Director, Preclinical Safety Assessment

Novartis

Gayathri Ramaswamy

Vice President, Drug Discovery & Disease Biology

Intergalactic Therapeutics

Gerard Caelles

Chief Business Officer

SpliceBio

Hemant Khanna

Vice President of Preclinical Ocular Research

IVERIC Bio

Jake Ternent

Patient

Luxturna

Jasmina Kapetanovic

Clinician & Consultant Vitreo-Retinal Surgeon

University of Oxford

Shannon Boye

Founder & Director

Atsena Therapeutics

Magali Taiel

Chief Medical Officer

GenSight Biologics

Richard Beckman

Chief Medical Officer

Adverum

Stephen Poor

Director of External Opportunities & Translational Biomarkers

Novartis

Steve Pakola

Chief Medical Officer

REGENXBIO

Stylianos Michalakis

Co-founder & Chief Scientific Advisor

ViGeneron

Theresa Heah

President & Chief Medical Officer

Kriya Ophthalmology

William Beltran

Director, Division of Experimental Retinal Therapies

University of Pennsylvania